Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise - PubMed (original) (raw)
. 2007 Jan 24;129(3):635-44.
doi: 10.1021/ja065697o.
Affiliations
- PMID: 17227027
- DOI: 10.1021/ja065697o
Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise
Garrett E Whitworth et al. J Am Chem Soc. 2007.
Abstract
O-GlcNAcase catalyzes the cleavage of beta-O-linked 2-acetamido-2-deoxy-beta-d-glucopyranoside (O-GlcNAc) from serine and threonine residues of post-translationally modified proteins. Two potent inhibitors of this enzyme are O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) and 1,2-dideoxy-2'-methyl-alpha-d-glucopyranoso[2,1-d]-Delta2'-thiazoline (NAG-thiazoline). Derivatives of these inhibitors differ in their selectivity for human O-GlcNAcase over the functionally related human lysosomal beta-hexosamindases, with PUGNAc derivatives showing modest selectivities and NAG-thiazoline derivatives showing high selectivities. The molecular basis for this difference in selectivities is addressed as is how well these inhibitors mimic the O-GlcNAcase-stabilized transition state (TS). Using a series of substrates, ground state (GS) inhibitors, and transition state mimics having analogous structural variations, we describe linear free energy relationships of log(KM/kcat) versus log(KI) for PUGNAc and NAG-thiazoline. These relationships suggest that PUGNAc is a poor transition state analogue, while NAG-thiazoline is revealed as a transition state mimic. Comparative X-ray crystallographic analyses of enzyme-inhibitor complexes reveal subtle molecular differences accounting for the differences in selectivities between these two inhibitors and illustrate key molecular interactions. Computational modeling of species along the reaction coordinate, as well as PUGNAc and NAG-thiazoline, provide insight into the features of NAG-thiazoline that resemble the transition state and reveal where PUGNAc fails to capture significant binding energy. These studies also point to late transition state poise for the O-GlcNAcase catalyzed reaction with significant nucleophilic participation and little involvement of the leaving group. The potency of NAG-thiazoline, its transition state mimicry, and its lack of traditional transition state-like design features suggest that potent rationally designed glycosidase inhibitors can be developed that exploit variation in transition state poise.
Similar articles
- Computational analysis of human OGA structure in complex with PUGNAc and NAG-thiazoline derivatives.
de Alencar NA, Sousa PR, Silva JR, Lameira J, Alves CN, Martí S, Moliner V. de Alencar NA, et al. J Chem Inf Model. 2012 Oct 22;52(10):2775-83. doi: 10.1021/ci2006005. Epub 2012 Sep 18. J Chem Inf Model. 2012. PMID: 22937904 - A quantum mechanics/molecular mechanics study of the protein-ligand interaction of two potent inhibitors of human O-GlcNAcase: PUGNAc and NAG-thiazoline.
Lameira J, Alves CN, Moliner V, Martí S, Kanaan N, Tuñón I. Lameira J, et al. J Phys Chem B. 2008 Nov 13;112(45):14260-6. doi: 10.1021/jp804626j. Epub 2008 Oct 22. J Phys Chem B. 2008. PMID: 18939790 - Enzyme molecular mechanism as a starting point to design new inhibitors: a theoretical study of O-GlcNAcase.
Lameira J, Alves CN, Tuñón I, Martí S, Moliner V. Lameira J, et al. J Phys Chem B. 2011 May 26;115(20):6764-75. doi: 10.1021/jp202079e. Epub 2011 May 4. J Phys Chem B. 2011. PMID: 21542586 - Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Bolanle IO, Riches-Suman K, Williamson R, Palmer TM. Bolanle IO, et al. Pharmacol Res. 2021 Mar;165:105467. doi: 10.1016/j.phrs.2021.105467. Epub 2021 Jan 27. Pharmacol Res. 2021. PMID: 33515704 Review. - O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?
Alonso J, Schimpl M, van Aalten DM. Alonso J, et al. J Biol Chem. 2014 Dec 12;289(50):34433-9. doi: 10.1074/jbc.R114.609198. Epub 2014 Oct 21. J Biol Chem. 2014. PMID: 25336650 Free PMC article. Review.
Cited by
- Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology.
Gloster TM, Vocadlo DJ. Gloster TM, et al. Nat Chem Biol. 2012 Jul 18;8(8):683-94. doi: 10.1038/nchembio.1029. Nat Chem Biol. 2012. PMID: 22810773 Review. - Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes.
Macauley MS, He Y, Gloster TM, Stubbs KA, Davies GJ, Vocadlo DJ. Macauley MS, et al. Chem Biol. 2010 Sep 24;17(9):937-48. doi: 10.1016/j.chembiol.2010.07.006. Chem Biol. 2010. PMID: 20851343 Free PMC article. - Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
Bullen JW, Balsbaugh JL, Chanda D, Shabanowitz J, Hunt DF, Neumann D, Hart GW. Bullen JW, et al. J Biol Chem. 2014 Apr 11;289(15):10592-10606. doi: 10.1074/jbc.M113.523068. Epub 2014 Feb 21. J Biol Chem. 2014. PMID: 24563466 Free PMC article. - Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
Zachara NE, Vosseller K, Hart GW. Zachara NE, et al. Curr Protoc Protein Sci. 2011 Nov;Chapter 12:12.8.1-12.8.33. doi: 10.1002/0471140864.ps1208s66. Curr Protoc Protein Sci. 2011. PMID: 22045558 Free PMC article. - Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.
Groves JA, Lee A, Yildirir G, Zachara NE. Groves JA, et al. Cell Stress Chaperones. 2013 Sep;18(5):535-58. doi: 10.1007/s12192-013-0426-y. Epub 2013 Apr 26. Cell Stress Chaperones. 2013. PMID: 23620203 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources